SCM
JAZZ icon

Shelton Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Shelton Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$474K Sell
1,967
-56
-3% -$12.3K 0.01% 375
2026
Q1 		$382K Hold
2,023
– – 0.01% 435
2025
Q4 		$344K Sell
2,023
-148
-7% -$22.7K 0.01% 455
2025
Q3 		$286K Hold
2,171
– – 0.01% 526
2025
Q2 		$230K Hold
2,171
– – 0.01% 608
2025
Q1 		$270K Sell
2,171
-159
-7% -$20.7K 0.01% 520
2024
Q4 		$287K Sell
2,330
-171
-7% -$20.2K 0.01% 522
2024
Q3 		$279K Hold
2,501
– – 0.01% 539
2024
Q2 		$267K Sell
2,501
-158
-6% -$17.4K 0.01% 540
2024
Q1 		$320K Sell
2,659
-105
-4% -$12.9K 0.01% 497
2023
Q4 		$340K Sell
2,764
-218
-7% -$27.2K 0.01% 438
2023
Q3 		$386K Sell
2,982
-147
-5% -$19.6K 0.01% 366
2023
Q2 		$388K Hold
3,129
– – 0.01% 383
2023
Q1 		$458K Hold
3,129
– – 0.02% 317
2022
Q4 		$498K Hold
3,129
– – 0.05% 272
2022
Q3 		$417K Hold
3,129
– – 0.02% 343
2022
Q2 		$488K Hold
3,129
– – 0.02% 326
2022
Q1 		$487K Hold
3,129
– – 0.02% 366
2021
Q4 		$399K Hold
3,129
– – 0.01% 443
2021
Q3 		$407K Hold
3,129
– – 0.02% 424
2021
Q2 		$556K Buy
3,129
+203
+7% +$35.2K 0.02% 354
2021
Q1 		$481K Hold
2,926
– – 0.02% 398
2020
Q4 		$483K Buy
+2,926
New +$436K 0.02% 354

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Shelton Capital Management's JAZZ Position: Q2 2026 in Review

Shelton Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.8% in Q2 2026, selling an estimated $12.3K and leaving 1,967 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #375.

Shelton Capital Management first reported a position in JAZZ in Q4 2020 and has held it in 23 quarters since. The position peaked at $556K in Q2 2021. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Shelton Capital Management held 1,967 shares of Jazz Pharmaceuticals worth $474K as of Q2 2026.
  • Shelton Capital Management sold 56 Jazz Pharmaceuticals shares in Q2 2026, an estimated $12.3K.
  • Jazz Pharmaceuticals made up 0.01% of Shelton Capital Management's portfolio in Q2 2026, its #375 holding.
  • Shelton Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Shelton Capital Management's Jazz Pharmaceuticals position peaked at $556K in Q2 2021.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.